Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Oscar Health, Inc. (NYSE:OSCR) have been given a consensus rating of “Hold” by the twelve ratings firms that are presently covering the company, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, seven have given a hold recommendation, two have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $19.2222.

A number of equities analysts recently commented on the stock. Wolfe Research assumed coverage on shares of Oscar Health in a research report on Tuesday, May 5th. They issued a “peer perform” rating on the stock. Robert W. Baird lifted their target price on shares of Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Barclays lifted their target price on shares of Oscar Health from $21.00 to $30.00 and gave the stock an “equal weight” rating in a research report on Tuesday. Weiss Ratings reiterated a “sell (d)” rating on shares of Oscar Health in a research report on Tuesday, April 21st. Finally, Jefferies Financial Group raised shares of Oscar Health from an “underperform” rating to a “hold” rating and raised their price target for the stock from $10.00 to $16.00 in a report on Monday, April 20th.

Insiders Place Their Bets

In other news, CEO Mark T. Bertolini purchased 1,000,000 shares of the business’s stock in a transaction on Monday, April 6th. The shares were acquired at an average price of $11.92 per share, with a total value of $11,920,000.00. Following the acquisition, the chief executive officer directly owned 10,196,876 shares in the company, valued at approximately $121,546,761.92. The trade was a 10.87% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Richard Scott Blackley sold 100,000 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $23.16, for a total transaction of $2,316,000.00. Following the completion of the sale, the chief financial officer directly owned 1,216,660 shares in the company, valued at approximately $28,177,845.60. This trade represents a 7.59% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 24.39% of the stock is owned by company insiders.

Institutional Investors Weigh In On Oscar Health

A number of large investors have recently added to or reduced their stakes in OSCR. Thrive Capital Management LLC grew its holdings in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. bought a new stake in Oscar Health in the first quarter valued at $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Oscar Health by 4.3% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after purchasing an additional 8,879 shares during the period. Jones Financial Companies Lllp raised its holdings in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Oscar Health by 39.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock worth $6,169,000 after purchasing an additional 132,149 shares in the last quarter. Institutional investors own 75.70% of the company’s stock.

Oscar Health Price Performance

Shares of NYSE:OSCR opened at $21.93 on Wednesday. The stock has a market cap of $6.61 billion, a PE ratio of -37.17, a PEG ratio of 1.58 and a beta of 2.34. The company’s fifty day moving average is $16.86 and its 200 day moving average is $15.66. Oscar Health has a 52 week low of $10.69 and a 52 week high of $25.58. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping analysts’ consensus estimates of $1.11 by $0.96. The company had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The firm’s revenue was up 52.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.92 EPS. Research analysts anticipate that Oscar Health will post 0.47 earnings per share for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.